Join us in recognizing World Cord Blood Day today to raise awareness about cord blood education. Through our Cord Blood Program and partnership with our global network, we're committed to protecting this valuable graft source, advocating for its appropriate use and promoting its potential to expand access to treatment for patients in need. Find out how we're democratizing cell therapy through cord blood ?? https://lnkd.in/gUdSfDqW #WorldCordBloodDay #WCBD24 #NMDP
NMDP的动态
最相关的动态
-
For US #HCPs: the Phase 2 CONVERGE study (NCT06667908) is now enrolling patients with non-small cell #LungCancer. Read more here: https://lnkd.in/eTE6GvQP
-
Featured Research article from our latest JFMB 2nd issue Vol.66 concludes that: ?Procalcitonin and nitric oxide may have a role in the diagnosis of acute bronchitis, in addition to lymphocytes and neutrophils. https://lnkd.in/eRf_n8Hr
Featured Research article from our latest JFMB 2nd issue Vol.66 concludes that: ?Procalcitonin and nitric oxide may have a role in the diagnosis of acute bronchitis, in addition to lymphocytes and neutrophils. https://lnkd.in/eb67weCA
-
-
Take a few simple steps to start your journey with us!?? We love to speak to potential clients and ensure they are well informed about the cold atmospheric plasma technology and understand how the Human Regenerator works at a cellular level before choosing us to be a part of their wellness journey! ?
Here’s a quick snapshot of what your journey with us will be like!?????? 1??Arrange a FREE discovery call with us once you enquire about our services. 2??Visit us at our clinic for your session for your pre-appointment consultation, we will maintain a session log to monitor your progress. 3??Applicators are placed on your hands and feet or in the areas of concern. 4??Once you are comfortable, enjoy your relaxing 30 minutes of advanced cell regeneration therapy. Get in touch to find out more about how our Human Regenerator can help you or someone you know! ??
-
10,000 patients treated with our cell therapies: This milestone is more than a number—it reflects how we transform patients’ lives through science and the dedication of countless individuals working together to bring #CARTcelltherapy to life. Driven by our teams’ expertise and commitment to advancing care, we are asking “What if?” to challenging questions in pursuit of better outcomes for patients. We’re expanding access to cell therapy to deliver on the promise of innovation. Thank you to the patients, families and healthcare professionals who make this progress possible. Together, we’re shaping a brighter future for patients worldwide. https://bit.ly/3Dc6vfj #OnACellularLevel
-
Medicinal Chemist | Targeted Protein Degradation & MedChem Passionate | All opinions are my own
????New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them #TPD #Targeted_Protein_Degradation
-
Cell therapy, particularly the #CART approach, has been expanding into the autoimmune disease field in recent years, with diseases like #lupus and #multiplesclerosis developing as areas of promise for development. But, although promising, the safety, efficacy, and broad applicability remain uncertain. CGTLive and HCPLive took a collaborative look into this, with commentary from Jack Arnold, MBBS, MRCP; Stacie Bell, PhD; Georg Schett, MD; Daniela van Eickels MD, PhD, MPH; and Zachary J Roberts MD PhD. https://lnkd.in/gyvfHhXt
-
Vice President | Immuno-Oncology | Cell Therapy | Hematology | Drug Development | Bristol-Myers Squibb | Physician
New treatment options that directly address the underlying condition are needed for autoimmune diseases. As co-chair of Bristol Myers Squibb’s recently formed ACTioN, I am thrilled to connect with this group of leaders in #CARTcelltheray and #immunology at #EULAR2024 to discuss our collective goal of discovering how cell therapy can transform the treatment landscape. Visit our ACTioN page on BMS.com to learn more about the potential of cell therapy in immunology: https://rb.gy/92nksr #BMS_Employee
Inspired by the potential of #CARTcelltherapy to advance the care of patients living with serious autoimmune diseases, we are building a network of experts to join forces and, together, reimagine the future of treatment for these patients. Collaboration is critical to make new discoveries and accelerate innovative treatments for patients. This year at #EULAR2024, we are convening a group of ACTioN members to help us chart a path to unlock the potential of cell therapy for the treatment of certain serious autoimmune diseases with urgent unmet needs. Learn more about how we plan to take action with ACTioN: https://bit.ly/3Xl0Yex
-
-
New Publication! Treatment patterns and #RealWorldOutcomes in patients with brain metastases secondary to HR+, HER2- #MetastaticBreastCancer treated with a CDK4/6 inhibitor and local intracranial therapy. See the full publication here: https://e.lilly/3A7MjKA #BCSM #BreastCancer
-
-
British researchers have unveiled a second-generation CAR-T therapy, reporting promising findings in an early trial involving patients with treatment resistant B-cell acute lymphoblastic leukaemia. Read the latest #BSHNews story here: https://ow.ly/w7oj50UnmRp
-
